# REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma

> **NCT06299306** · — · TERMINATED · sponsor: **AstraZeneca** · enrollment: 19 (actual)

## Conditions studied

- Asthma, Bronchial

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06299306
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-05-07
- **Primary completion:** 2024-11-25
- **Final completion:** 2024-11-25
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** The early termination of the study is due to challenging recruitment of study sites and patients.
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06299306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06299306, "REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06299306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*